LAUSR

Copolymers synthesized from acrylic acid and methacrylic acid used as gastroprotective and mucoadhesive enteric coatings have been used to prepare micro (~2 µm), submicro (~200 nm) and nanoparticles (~20 nm) containing rifampicin to obtain time-controlled drug release kinetics. Different particle sizes and drug release kinetics have been obtained by using different synthesis conditions and fabrication techniques including the use of an electrosprayer and an interdigital microfabricated micromixer. The antimicrobial action of the encapsulated rifampicin has been demonstrated against Staphylococcus aureus ATCC 25923 and compared with the effect of the equivalent dose of the free macrolide antibiotic. At low concentrations, the encapsulated antibiotic showed superior antimicrobial activity than the free drug. The stability of the developed particles has been evaluated in vitro under simulated gastric and intestinal conditions. At the concentrations tested, a reduced cytotoxicity against different human cell lines was observed after analyzing their subcytotoxic doses and the influence on their cell cycle by flow cytometry. Drug release kinetics can be tuned by adjusting particle sizes and it would be possible to reach the minimum inhibitory concentration (MIC) or the minimum bactericidal concentration (MBC) at different time points depending on the medical needs.